# Dynogen Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dynogen-pharmaceuticals

- Industry: Biotechnology
- Headquarters: Waltham, US
- Website: www.dynogen.com
- Total disclosed funding: $63M
- Latest round: Series B (Apr 19, 2004)
- Investors on record: 8

## About

Dynogen is a clinical-stage biopharmaceutical company developing innovative treatments for gastrointestinal and genitourinary disorders.

## Funding rounds

- Series B, Apr 19, 2004, $50M — Abingworth, Atlas Venture, HealthCare Ventures, Oxford Bioscience Partners, Wellcome Trust, Schroder Ventures, Medica Venture Partners, A. M. Pappas & Associates
- Series A, Nov 13, 2002, $13M — HealthCare Ventures, Oxford Bioscience Partners, A. M. Pappas & Associates

## Investors

- HealthCare Ventures — Series A, Series B
- Oxford Bioscience Partners (https://capitalatlas.ai/funds/oxford-bioscience-partners) — Series A, Series B
- A. M. Pappas & Associates — Series A, Series B
- Abingworth (https://capitalatlas.ai/funds/abingworth) — Series B
- Atlas Venture (https://capitalatlas.ai/funds/atlas-venture) — Series B
- Wellcome Trust — Series B
- Schroder Ventures (https://capitalatlas.ai/funds/schroder-ventures) — Series B
- Medica Venture Partners (https://capitalatlas.ai/funds/medica-venture-partners) — Series B